Trial Profile
A Phase I, Double-blind, Randomised, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Multiple Dosages of Estetrol in Healthy Men
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Estetrol (Primary)
- Indications Migraine; Osteoarthritis; Prostate cancer; Vasomotor symptoms
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Pantarhei Bioscience
- 08 Feb 2017 Status changed from active, no longer recruiting to completed.
- 23 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Nov 2016 Planned number of patients changed from 30 to 45.